New Insight into the Mechanism of Accumulation and Intraerythrocytic Compartmentation of Albitiazolium, a New Type of Antimalarial
- 1 September 2014
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (9) , 5519-5527
Abstract
Bis-thiazolium salts constitute a new class of antihematozoan drugs that inhibit parasite phosphatidylcholine biosynthesis. They specifically accumulate in Plasmodium - and Babesia -infected red blood cells (IRBC). Here, we provide new insight into the choline analogue albitiazolium, which is currently being clinically tested against severe malaria. Concentration-dependent accumulation in P. falciparum -infected erythrocytes reached steady state after 90 to 120 min and was massive throughout the blood cycle, with cellular accumulation ratios of up to 1,000. This could not occur through a lysosomotropic effect, and the extent did not depend on the food vacuole pH, which was the case for the weak base chloroquine. Analysis of albitiazolium accumulation in P. falciparum IRBC revealed a high-affinity component that was restricted to mature stages and suppressed by pepstatin A treatment, and thus likely related to drug accumulation in the parasite food vacuole. Albitiazolium also accumulated in a second high-capacity component present throughout the blood cycle that was likely not related to the food vacuole and also observed with Babesia divergens -infected erythrocytes. Accumulation was strictly glucose dependent, drastically inhibited by H + /K + and Na + ionophores upon collapse of ionic gradients, and appeared to be energized by the proton-motive force across the erythrocyte plasma membrane, indicating the importance of transport steps for this permanently charged new type of antimalarial agent. This specific, massive, and irreversible accumulation allows albitiazolium to restrict its toxicity to hematozoa-infected erythrocytes. The intraparasitic compartmentation of albitiazolium corroborates a dual mechanism of action, which could make this new type of antimalarial agent resistant to parasite resistance.Keywords
This publication has 47 references indexed in Scilit:
- Soft X-ray microscopy analysis of cell volume and hemoglobin content in erythrocytes infected with asexual and sexual stages of Plasmodium falciparumJournal of Structural Biology, 2012
- Reliability of Antimalarial Sensitivity Tests Depends on Drug Mechanisms of ActionJournal of Clinical Microbiology, 2010
- Artemisinin resistance: current status and scenarios for containmentNature Reviews Microbiology, 2010
- Targeting the lipid metabolic pathways for the treatment of malariaDrug Development Research, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Testing the hypothesis that amphiphilic antineoplastic lipid analogues act through reduction of membrane curvature elastic stressJournal of The Royal Society Interface, 2008
- Magnetic separation: a highly effective method for synchronization of cultured erythrocytic Plasmodium falciparumParasitology Research, 2008
- Potent Antihematozoan Activity of Novel Bisthiazolium Drug T16: Evidence for Inhibition of Phosphatidylcholine Metabolism in Erythrocytes Infected with Babesia and Plasmodium sppAntimicrobial Agents and Chemotherapy, 2006
- Heme Binding Contributes to Antimalarial Activity of Bis-Quaternary AmmoniumsAntimicrobial Agents and Chemotherapy, 2003
- Human Malaria Parasites in Continuous CultureScience, 1976